We start English website service. Thank you for waiting this.
CHA Vaccine Institute is a research-oriented biotechnology company. We research and develop a broad range of vaccine products targeting infectious disease as well as chronic disease.
The core technology we have achieved includes proprietary vaccine adjuvant L-pampo, recombinant antigen development platform. Using these platform technologies, we have developed improved prophylactic vaccine for the infectious disease and therapeutic vaccine for the chronic disease.